Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (161-170 of 1,725) with videos related to

Pageof 173
Sort By:
Advances in Protein Chemistry|May 2, 2001
Monoclonal antibody therapyJ W Park, J Smolen
Zeitschrift Fur Rheumatologie|December 20, 2002
[Novel autoantibodies for the diagnosis of rheumatoid arthritis]G Steiner, J S Smolen
Arthritis Research & Therapy|January 30, 2008
The role of tumor necrosis factor-alpha in systemic lupus erythematosusMartin Aringer, Josef S Smolen
Current Opinion in Rheumatology|June 3, 1998
Are autoantibodies active players or epiphenomena?J S Smolen, G Steiner
Arthritis Research & Therapy|June 26, 2003
SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosusMartin Aringer, Josef S Smolen
Advances in Prostaglandin and Thromboxane Research|January 1, 1980
Lysosomal enzyme release from human granulocytes is inhibited by indomethacin, ETYA, and BPBJ E Smolen, G Weissmann
Clinical and Experimental Rheumatology|November 7, 2006
Remission of rheumatoid arthritis: should we care about definitions?D Aletaha, J S Smolen
Arthritis and Rheumatism|September 29, 2011
Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen jointsDaniel Aletaha, Josef S Smolen
Reviews of Environmental Contamination and Toxicology|January 1, 1996
Epidemiological analysis of persistent organochlorine contaminants in cetaceansT Colborn, M J Smolen
Journal of Addictive Diseases|January 1, 1991
Genetic selections for nicotine and cocaine sensitivity in miceA Smolen, M J Marks
Pageof 173

Showing results (161-170 of 1,725) with videos related to

Sort By:
Pageof 173
Advances in Protein Chemistry|May 2, 2001
Monoclonal antibody therapyJ W Park, J Smolen
Zeitschrift Fur Rheumatologie|December 20, 2002
[Novel autoantibodies for the diagnosis of rheumatoid arthritis]G Steiner, J S Smolen
Arthritis Research & Therapy|January 30, 2008
The role of tumor necrosis factor-alpha in systemic lupus erythematosusMartin Aringer, Josef S Smolen
Current Opinion in Rheumatology|June 3, 1998
Are autoantibodies active players or epiphenomena?J S Smolen, G Steiner
Arthritis Research & Therapy|June 26, 2003
SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosusMartin Aringer, Josef S Smolen
Advances in Prostaglandin and Thromboxane Research|January 1, 1980
Lysosomal enzyme release from human granulocytes is inhibited by indomethacin, ETYA, and BPBJ E Smolen, G Weissmann
Clinical and Experimental Rheumatology|November 7, 2006
Remission of rheumatoid arthritis: should we care about definitions?D Aletaha, J S Smolen
Arthritis and Rheumatism|September 29, 2011
Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen jointsDaniel Aletaha, Josef S Smolen
Reviews of Environmental Contamination and Toxicology|January 1, 1996
Epidemiological analysis of persistent organochlorine contaminants in cetaceansT Colborn, M J Smolen
Journal of Addictive Diseases|January 1, 1991
Genetic selections for nicotine and cocaine sensitivity in miceA Smolen, M J Marks
Pageof 173